EliTechGroup Molecular Diagnostics, Puteaux, France, has launched a multiplex assay, the respiratory bacterial Elite MGB panel, for the diagnosis of bacterial respiratory infections. The panel was validated using the Elite InGenius, the company’s fully automated sample-to-result system.
In combination with Elite InGenius, the CE-marked panel is specifically designed to detect and differentiate C. pneumoniae, L. pneumophila, and M. pneumoniae in a single reaction. In its clinical study, the panel demonstrated 100% sensitivity and 100% specificity for all targets.
“We are proud to extend the Elite InGenius respiratory menu, which now enables laboratories to diagnose the main relevant virus and bacteria involved in respiratory infections,” says Christoph Gauer, chief executive of EliTechGroup. “Aligned with our menu expansion strategy, this new assay strengthens the Elite InGenius [offering], providing our customers with the largest CE IVD menu for infectious disease testing available on an integrated sample-to-result solution.”
The respiratory menu will be further broadened in the coming months, with a new real-time polymerase chain reaction assay for the detection of Mycobacterium tuberculosis species associated with multidrug resistance to rifampicin and isoniazid.
For more information, visit EliTechGroup.